glp 1 evolution History of GLP-1 Medications GLP-1 Analogues Market Size to

These insights should be interpreted with your healthcare provider as one piece of informationnot as a predictor of whether GLP-1 therapy will worsen gastroparesis in your specific case

All weight loss medications have some side effects, but FDA approval means the benefits are considered to outweigh the potential risks

Recently, the pharmacotherapy of MASLD mainly focuses on three parts of mechanisms: anti-inflammatory (ASK1 inhibitors), anti-diabetic (GCGR agonists, PPAR agonists), and prevention of lipotoxicity (FXR agonists, FGF21 analogues) (Wei et al., 2024)

Protein intake is essential to prevent muscle loss and maintain satiety while on GLP-1 medications (Locatelli et al., 2024)

Non-inferiority was proven for IDegLira compared to degludec (A1c 0.47%

Pharmacokinetic data showed that liraglutide has a longer half-life, about 9-13 hours [20], compared to the other short-acting GLP-1 Ras, such as exenatide (2.1 hours) [19]